Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Mathai, H. Champion, A. Zaiman, R. Girgis, P. Hassoun (Baltimore, MD, United States Of America). NT-proBNP correlation with disease severity in PAH-SSc versus IPAH. Eur Respir J 2008; 32: Suppl. 52, 1420

Member's Comments

No comment yet.

Related content which might interest you: NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004 Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 NT-proBNP variation in stable pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Microalbuminuria in patients with COPD: prevalence and correlations with pulmonary parameters Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (1) 00074-2016; 10.1183/23120541.00074-2016 Year: 2017 Is there any relationship between the duration to diagnosis of COPD and severity of the disease? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Degree of LVEF with respect to severity of COPD Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017 Year: 2018 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001